Rare
lephants
Screener
Toggle theme
Trinity Biotech plc
TRIB
·
Healthcare, Drug Manufacturers - General
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
Total Cash from Operations:
$7.2M
Line Item
Value
% of Total
Capital Expenditures
$3.7M
50.8%
Stock Repurchases
$139.0K
1.9%
Other Financing
$3.4M
47.3%
Net Cash Flow
$0
0.0%
Download CSV
